{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:51:37Z","timestamp":1792097497081,"version":"4.4.0"},"reference-count":164,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Peripheral artery disease (PAD) is a common and serious complication in people with chronic kidney disease (CKD) and end-stage kidney disease, occurring four to six times more frequently than in the general population. PAD is characterized by atherosclerotic narrowing or occlusion of peripheral arteries, leads to lower limb ischaemia, and is associated with increased morbidity and mortality. People with CKD and PAD are at higher risk for cardiovascular events and presence of chronic limb-threatening ischaemia further doubles mortality risk in this population. The pathophysiology of PAD in CKD is multifactorial, involving endothelial dysfunction, inflammation, oxidative stress and disordered mineral metabolism; these are key CKD features that exacerbate vascular disease. Traditional risk factors, such as diabetes, hypertension, dyslipidaemia and smoking, also contribute to the development of PAD. Mineral imbalances and metabolic disturbances, seen in CKD-related mineral bone disorders (MBD), including vitamin D deficiency, are an emerging interest area in the development of PAD. Diagnosing PAD in CKD is challenging due to symptom overlap; non-invasive and inexpensive diagnostic tools such as ankle brachial index and toe brachial index offer potential for routine screening. Management of PAD is largely based on guidelines for the general population overlooking the unique differences in CKD patients. A multifaceted approach is fundamental (including lifestyle modifications, pharmacotherapy and, in some cases, revascularization procedures). This comprehensive review (i) outlines the epidemiology, aetiology and pathophysiology of PAD in CKD, (ii) discusses the role of CKD-MBD in PAD and (iii) highlights ongoing studies and the future therapeutic landscape.<\/jats:p>","DOI":"10.1093\/ckj\/sfaf089","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:25:22Z","timestamp":1744082722000},"source":"Crossref","is-referenced-by-count":21,"title":["Clinical management of peripheral arterial disease in chronic kidney disease\u2014a comprehensive review from the European Renal Association CKD-MBD Working Group"],"prefix":"10.1093","volume":"18","author":[{"given":"Sharon","family":"Huish","sequence":"first","affiliation":[{"name":"Royal Devon University Healthcare NHS Foundation Trust, and University of Exeter Department of Renal Dietetics, , Exeter ,","place":["UK"]},{"name":"Northern Care Alliance NHS Foundation Trust Department of Renal Medicine, , Salford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira","family":"Nawaz","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust Department of Renal Medicine, , Salford ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bellasi","sequence":"additional","affiliation":[{"name":"Service of Nephrology, Ospedale Regionale di Lugano, Ospedale Civico, Ente Ospedaliero Cantonale , Lugano ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Diaz-Tocados","sequence":"additional","affiliation":[{"name":"Vascular and Renal Translational Research Group, Institut de Recerca Biom\u00e8dica de Lleida , Lleida ,","place":["Spain"]},{"name":"Universitat de Lleida , Departament d\u2019Infermeria i Fisioter\u00e0pia, Lleida ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8274-6356","authenticated-orcid":false,"given":"Mathias","family":"Haarhaus","sequence":"additional","affiliation":[{"name":"Intervention and Technology, Karolinska Institutet, Karolinska University Hospital Division of Renal Medicine, Department of Clinical Science, , Huddinge, Stockholm ,","place":["Sweden"]},{"name":"Diaverum AB , Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4117-4085","authenticated-orcid":false,"given":"Smeeta","family":"Sinha","sequence":"additional","affiliation":[{"name":"Northern Care Alliance NHS Foundation Trust Department of Renal Medicine, , Salford ,","place":["UK"]},{"name":"Faculty of Biology, Medicine & Health, The University of Manchester , Manchester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"2025050207470501700_bib1","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","article-title":"ACC\/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery\/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC\/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"key":"2025050207470501700_bib2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4065\/mcp.2010.0133","article-title":"Peripheral artery disease: current insight into the disease and its diagnosis and management","volume":"85","author":"Olin","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"2025050207470501700_bib3","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","article-title":"Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis","volume":"7","author":"Song","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2025050207470501700_bib4","doi-asserted-by":"publisher","first-page":"10760296211025625","DOI":"10.1177\/10760296211025625","article-title":"National trends for peripheral artery disease and end stage renal disease from the national inpatient sample database","volume":"27","author":"De Stefano","year":"2021","journal-title":"Clin Appl Thromb Hemost"},{"key":"2025050207470501700_bib5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.atherosclerosis.2018.05.033","article-title":"Update on peripheral artery disease: epidemiology and evidence-based facts","volume":"275","author":"Shu","year":"2018","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00059-008-3152-y","article-title":"Coronary, peripheral and cerebrovascular disease: a complex relationship","volume":"33","author":"Shah","year":"2008","journal-title":"Herz"},{"key":"2025050207470501700_bib7","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1111\/j.1523-1755.2005.09310.x","article-title":"Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors","volume":"67","author":"de Vinuesa","year":"2005","journal-title":"Kidney Int"},{"key":"2025050207470501700_bib8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/nep.13914","article-title":"Prevalence and risk factors of peripheral artery disease in a population with chronic kidney disease in Australia: a systematic review and meta-analysis","volume":"26","author":"Ho","year":"2021","journal-title":"Nephrology"},{"key":"2025050207470501700_bib9","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1681\/ASN.V12122838","article-title":"Lower-extremity peripheral arterial disease among patients with end-stage renal disease","volume":"12","author":"O'Hare","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib10","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2215\/CJN.04101206","article-title":"Peripheral arterial disease: a guide for nephrologists","volume":"2","author":"DeLoach","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025050207470501700_bib11","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1093\/ndt\/gfl470","article-title":"Peripheral arterial disease in patients with stages IV and V chronic renal failure","volume":"21","author":"Guerrero","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2025050207470501700_bib12","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","article-title":"Peripheral artery disease: past, present, and future","volume":"132","author":"Campia","year":"2019","journal-title":"Am J Med"},{"key":"2025050207470501700_bib13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"key":"2025050207470501700_bib14","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.3390\/jcm10194467","article-title":"Prevalence of peripheral arterial disease and associated vascular risk factors in 65-years-old people of northern Barcelona","volume":"10","author":"Gon\u00e7alves-Martins","year":"2021","journal-title":"J Clin Med"},{"key":"2025050207470501700_bib15","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte","year":"2019","journal-title":"J Vasc Surg"},{"key":"2025050207470501700_bib16","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.ackd.2014.07.005","article-title":"Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes","volume":"21","author":"Garimella","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"2025050207470501700_bib17","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/ATVBAHA.120.314824","article-title":"Fibrosis and inflammatory markers and long-term risk of peripheral artery disease: the ARIC study","volume":"40","author":"Ding","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025050207470501700_bib18","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1161\/CIRCULATIONAHA.106.683722","article-title":"Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"2025050207470501700_bib19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12933-017-0581-z","article-title":"Serum high mobility group box-1 and osteoprotegerin levels are associated with peripheral arterial disease and critical limb ischemia in type 2 diabetic subjects","volume":"16","author":"Giovannini","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"2025050207470501700_bib20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/09629350410001664752","article-title":"Monocyte chemoattractant protein-1 in patients with peripheral arterial disease","volume":"13","author":"Petrkova","year":"2004","journal-title":"Mediators Inflamm"},{"key":"2025050207470501700_bib21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1161\/ATVBAHA.110.210385","article-title":"Genetic influences on peripheral arterial disease in a twin population","volume":"31","author":"Wahlgren","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025050207470501700_bib22","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jacc.2011.06.023","article-title":"Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study","volume":"58","author":"Wassel","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2025050207470501700_bib23","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.amjcard.2014.06.029","article-title":"Family history as a risk factor for peripheral arterial disease","volume":"114","author":"Khaleghi","year":"2014","journal-title":"Am J Cardiol"},{"key":"2025050207470501700_bib24","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s41591-019-0492-5","article-title":"Genome-wide association study of peripheral artery disease in the Million Veteran Program","volume":"25","author":"Klarin","year":"2019","journal-title":"Nat Med"},{"key":"2025050207470501700_bib25","doi-asserted-by":"publisher","first-page":"e002862","DOI":"10.1161\/CIRCGEN.119.002862","article-title":"Genome-wide association study of peripheral artery disease","volume":"14","author":"van Zuydam","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2025050207470501700_bib26","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.medcle.2023.06.011","article-title":"Peripheral artery disease: update on etiology, pathophysiology, diagnosis and treatment","volume":"161","author":"Mandaglio-Collados","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"2025050207470501700_bib27","doi-asserted-by":"publisher","first-page":"V303","DOI":"10.1016\/S0049-3848(01)00366-8","article-title":"Evaluation of patients with peripheral vascular disease","volume":"106","author":"Halperin","year":"2002","journal-title":"Thromb Res"},{"key":"2025050207470501700_bib28","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"2025050207470501700_bib29","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1161\/CIRCULATIONAHA.105.607390","article-title":"Peripheral arterial disease in patients with end-stage renal disease: observations from the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"114","author":"Rajagopalan","year":"2006","journal-title":"Circulation"},{"key":"2025050207470501700_bib30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/1471-2458-10-731","article-title":"Association between smoking and chronic kidney disease: a case control study","volume":"10","author":"Yacoub","year":"2010","journal-title":"BMC Public Health"},{"key":"2025050207470501700_bib31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and disease burden of chronic kidney disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"2025050207470501700_bib32","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"2025050207470501700_bib33","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2025050207470501700_bib34","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/ndt\/gfv418","article-title":"Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease","volume":"31","author":"Chen","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2025050207470501700_bib35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0272-6386(99)70392-6","article-title":"Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease","volume":"34","author":"Manns","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"2025050207470501700_bib36","doi-asserted-by":"publisher","first-page":"e013934","DOI":"10.1161\/JAHA.119.013934","article-title":"Association between homocysteine and vascular calcification incidence, prevalence, and progression in the MESA cohort","volume":"9","author":"Karger","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2025050207470501700_bib37","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/bph.13988","article-title":"Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets","volume":"175","author":"Fu","year":"2018","journal-title":"Br J Pharmacol"},{"key":"2025050207470501700_bib38","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1210\/jc.2018-00136","article-title":"Association of vitamin D deficiency with peripheral arterial disease: a meta-analysis of literature studies","volume":"103","author":"Iannuzzo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025050207470501700_bib39","first-page":"106","article-title":"The role of vitamin D for cardiovascular disease and overall mortality","volume":"810","author":"Zittermann","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"2025050207470501700_bib40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ejvs.2012.06.017","article-title":"Vitamin D deficiency may be an independent risk factor for arterial disease","volume":"44","author":"van de Luijtgaarden","year":"2012","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025050207470501700_bib41","first-page":"69","article-title":"Vitamin D and inflammatory diseases","volume":"7","author":"Yin","year":"2014","journal-title":"J Inflamm Res"},{"key":"2025050207470501700_bib42","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.3390\/nu13103603","article-title":"Vitamin D and cardiovascular disease: current evidence and future perspectives","volume":"13","author":"Cosentino","year":"2021","journal-title":"Nutrients"},{"key":"2025050207470501700_bib43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1681\/ASN.V132497","article-title":"Peripheral vascular disease risk factors among patients undergoing hemodialysis","volume":"13","author":"O'Hare","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1053\/j.ajkd.2003.08.045","article-title":"Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD","volume":"43","author":"Cooper","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2025050207470501700_bib45","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"2025050207470501700_bib46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2018.04.014","article-title":"Human serum albumin in cardiovascular diseases","volume":"52","author":"Arques","year":"2018","journal-title":"Eur J Intern Med"},{"key":"2025050207470501700_bib47","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1111\/jch.14071","article-title":"Association between serum albumin and peripheral arterial disease in hypertensive patients","volume":"22","author":"Ding","year":"2020","journal-title":"J Clin Hypertens"},{"key":"2025050207470501700_bib48","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2007.12.044","article-title":"Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA)","volume":"201","author":"Wattanakit","year":"2008","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: pathogenesis and clinical significance","volume":"43","author":"Soeters","year":"2019","journal-title":"J Parenter Enteral Nutr"},{"key":"2025050207470501700_bib50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1053\/j.ajkd.2004.03.022","article-title":"The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study","volume":"44","author":"Barzilay","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"2025050207470501700_bib51","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0140-6736(92)91401-S","article-title":"Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus","volume":"340","author":"Stehouwer","year":"1992","journal-title":"Lancet"},{"key":"2025050207470501700_bib52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0021-9150(92)90201-Q","article-title":"Microalbuminuria and associated cardiovascular risk factors in the community","volume":"93","author":"Winocour","year":"1992","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1053\/j.ajkd.2011.03.018","article-title":"Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis","volume":"58","author":"Mehrotra","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"2025050207470501700_bib54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2012.11.034","article-title":"Serum albumin and C-reactive protein levels predict clinical outcome in hemodialysis patients undergoing endovascular therapy for peripheral artery disease","volume":"227","author":"Ishii","year":"2013","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib55","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3390\/toxins12120808","article-title":"Targeting uremic toxins to prevent peripheral vascular complications in chronic kidney disease","volume":"12","author":"Wu","year":"2020","journal-title":"Toxins"},{"key":"2025050207470501700_bib56","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1161\/01.RES.0000218859.90970.8d","article-title":"Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway","volume":"98","author":"Son","year":"2006","journal-title":"Circ Res"},{"key":"2025050207470501700_bib57","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/ki.2013.213","article-title":"Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification","volume":"84","author":"Finch","year":"2013","journal-title":"Kidney Int"},{"key":"2025050207470501700_bib58","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/toxins12080472","article-title":"Scavenging intracellular ROS attenuates p-cresyl sulfate-triggered osteogenesis through MAPK signaling pathway and NF-\u03baB activation in human arterial smooth muscle cells","volume":"12","author":"Chang","year":"2020","journal-title":"Toxins"},{"key":"2025050207470501700_bib59","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1681\/ASN.2018060609","article-title":"Indoxyl sulfate and p-cresyl sulfate promote vascular calcification and associate with glucose intolerance","volume":"30","author":"Opdebeeck","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib60","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/toxins14040287","article-title":"Serum p-cresyl sulfate level is an independent marker of peripheral arterial stiffness as assessed using brachial-ankle pulse wave velocity in patients with non-dialysis chronic kidney disease stage 3 to 5","volume":"14","author":"Chang","year":"2022","journal-title":"Toxins"},{"key":"2025050207470501700_bib61","doi-asserted-by":"publisher","first-page":"e948","DOI":"10.1097\/MD.0000000000000948","article-title":"Elevated blood urea nitrogen is associated with critical limb ischemia in peripheral arterial disease patients","volume":"94","author":"Gary","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025050207470501700_bib62","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000335198","article-title":"Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease","volume":"1","author":"Shiotsu","year":"2011","journal-title":"Nephron Extra"},{"key":"2025050207470501700_bib63","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"2025050207470501700_bib64","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1001\/jamacardio.2019.0375","article-title":"Risk of cardiovascular disease and mortality in young adults with end-stage renal disease: an analysis of the US Renal Data System","volume":"4","author":"Modi","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025050207470501700_bib65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"2025050207470501700_bib66","first-page":"313","article-title":"Peripheral arterial disease and kidney failure: a frequent association","volume":"32","author":"Tranche-Iparraguirre","year":"2012","journal-title":"Nefrologia"},{"key":"2025050207470501700_bib67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1471-2369-13-100","article-title":"Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan","volume":"13","author":"Lee","year":"2012","journal-title":"BMC Nephrol"},{"key":"2025050207470501700_bib68","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/ehjqcco\/qcw057","article-title":"Long-term survival and fate of the leg in de novo intermittent claudication","volume":"3","author":"Kumakura","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2025050207470501700_bib69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/14779072.2023.2174525","article-title":"The pathophysiology and management of vascular calcification in chronic kidney disease patients","volume":"21","author":"Kanbay","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2025050207470501700_bib70","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.kint.2018.12.014","article-title":"Arterial \u201cinflammaging\u201d drives vascular calcification in children on dialysis","volume":"95","author":"Sanchis","year":"2019","journal-title":"Kidney Int"},{"key":"2025050207470501700_bib71","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1007\/s00467-008-1046-0","article-title":"Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease","volume":"24","author":"Silverstein","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"2025050207470501700_bib72","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.atherosclerosis.2011.02.017","article-title":"Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease\u2014a cross-sectional study of predialysis, dialysis and kidney-transplantation patients","volume":"216","author":"Recio-Mayoral","year":"2011","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib73","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.transproceed.2015.11.005","article-title":"Mortality on the kidney waiting list and after transplantation in patients with peripheral arterial disease: an analysis of the United States Renal Data System","volume":"48","author":"Brar","year":"2016","journal-title":"Transplant Proc"},{"key":"2025050207470501700_bib74","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.amjcard.2012.02.061","article-title":"Risk factors for peripheral arterial disease among patients with chronic kidney disease","volume":"110","author":"Chen","year":"2012","journal-title":"Am J Cardiol"},{"key":"2025050207470501700_bib75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/sdi.12255","article-title":"Thrombosis in the uremic milieu\u2014emerging role of \u201cthrombolome\u201d","volume":"28","author":"Shashar","year":"2015","journal-title":"Semin Dial"},{"key":"2025050207470501700_bib76","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000351758","article-title":"Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am J Nephrol"},{"key":"2025050207470501700_bib77","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.atherosclerosis.2012.07.012","article-title":"The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis","volume":"225","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib78","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1681\/ASN.2014121241","article-title":"The aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia","volume":"27","author":"Shivanna","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib79","doi-asserted-by":"publisher","first-page":"e142260","DOI":"10.1172\/JCI142260","article-title":"Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease","volume":"132","author":"Arinze","year":"2022","journal-title":"J Clin Invest"},{"key":"2025050207470501700_bib80","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1523-1755.2004.00784.x","article-title":"Uremia causes endothelial progenitor cell deficiency","volume":"66","author":"de Groot","year":"2004","journal-title":"Kidney Int"},{"key":"2025050207470501700_bib81","doi-asserted-by":"publisher","first-page":"H1414","DOI":"10.1152\/ajpheart.00272.2018","article-title":"FGF23 impairs peripheral microvascular function in renal failure","volume":"315","author":"Verkaik","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025050207470501700_bib82","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2019.12.008","article-title":"Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study","volume":"74","author":"Rodr\u00edguez-Ortiz","year":"2020","journal-title":"Eur J Intern Med"},{"key":"2025050207470501700_bib83","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.3390\/ijms25105457","article-title":"FGF23 as a potential pathophysiological factor in peripheral arterial disease associated with chronic kidney disease","volume":"25","author":"Donate-Correa","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2025050207470501700_bib84","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1681\/ASN.2014020169","article-title":"Ankle-brachial index and bone turnover in patients on dialysis","volume":"26","author":"London","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib85","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2020.04.022","article-title":"Association of serum phosphate concentration with the incidence of intervention for peripheral artery disease in patients undergoing hemodialysis: 10-year outcomes of the Q-Cohort Study","volume":"304","author":"Shimamoto","year":"2020","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib86","doi-asserted-by":"publisher","first-page":"15877","DOI":"10.1038\/s41598-021-95488-4","article-title":"Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease","volume":"11","author":"Donate-Correa","year":"2021","journal-title":"Sci Rep"},{"key":"2025050207470501700_bib87","doi-asserted-by":"publisher","first-page":"899307","DOI":"10.3389\/fcvm.2022.899307","article-title":"Associations between serum soluble \u03b1-Klotho and the prevalence of specific cardiovascular disease","volume":"9","author":"Xu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2025050207470501700_bib88","doi-asserted-by":"publisher","first-page":"8422","DOI":"10.1038\/s41598-022-12548-z","article-title":"Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease","volume":"12","author":"Mart\u00edn-N\u00fa\u00f1ez","year":"2022","journal-title":"Sci Rep"},{"key":"2025050207470501700_bib89","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/heartjnl-2013-304746","article-title":"Reduced Klotho is associated with the presence and severity of coronary artery disease","volume":"100","author":"Navarro-Gonz\u00e1lez","year":"2014","journal-title":"Heart"},{"key":"2025050207470501700_bib90","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2017.09.020","article-title":"Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease","volume":"267","author":"Yang","year":"2017","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib91","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"2025050207470501700_bib92","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1681\/ASN.2017010003","article-title":"A randomized trial of vitamin D supplementation on vascular function in CKD","volume":"28","author":"Kumar","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib93","doi-asserted-by":"publisher","first-page":"e109998","DOI":"10.1371\/journal.pone.0109998","article-title":"Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: data from a randomized controlled pilot trial","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"2025050207470501700_bib94","doi-asserted-by":"crossref","first-page":"644","DOI":"10.29271\/jcpsp.2021.06.644","article-title":"Relationship between vitamin D deficiency, albuminuria, peripheral artery disease and 5-year mortality in chronic kidney disease","volume":"31","author":"\u00d6zg\u00fcr","year":"2021","journal-title":"J Coll Physicians Surg Pak"},{"key":"2025050207470501700_bib95","first-page":"671","article-title":"Vitamin D status and peripheral arterial disease: evidence so far","volume":"7","author":"Chua","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"2025050207470501700_bib96","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/ndt\/gfae293","article-title":"The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation\u2014a European consensus statement","volume":"40","author":"J\u00f8rgensen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2025050207470501700_bib97","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.carrev.2019.09.001","article-title":"The renal foot\u201d\u2014angiographic pattern of patients with chronic limb threatening ischemia and end-stage renal disease","volume":"21","author":"Baghdasaryan","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"2025050207470501700_bib98","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.kjms.2012.08.014","article-title":"Risk factors of accelerated progression of peripheral artery disease in hemodialysis","volume":"29","author":"Hsu","year":"2013","journal-title":"Kaohsiung J Med Sci"},{"key":"2025050207470501700_bib99","doi-asserted-by":"crossref","first-page":"e042315","DOI":"10.1136\/bmjopen-2020-042315","article-title":"Peripheral artery disease at the time of dialysis initiation and mortality: a prospective observational multicenter study","volume":"10","author":"Hikaru","year":"2020","journal-title":"BMJ Open"},{"key":"2025050207470501700_bib100","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1053\/ajkd.2003.50033","article-title":"Prevalence and progression of peripheral arterial calcifications in patients with ESRD","volume":"41","author":"Kronenberg","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"2025050207470501700_bib101","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12882-019-1468-x","article-title":"Prevalence, clinical characteristics, and predictors of peripheral arterial disease in hemodialysis patients: a cross-sectional study","volume":"20","author":"A\u0161\u0107eri\u0107","year":"2019","journal-title":"BMC Nephrol"},{"key":"2025050207470501700_bib102","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.kint.2021.04.029","article-title":"Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"100","author":"Johansen","year":"2021","journal-title":"Kidney Int"},{"key":"2025050207470501700_bib103","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1136\/heartjnl-2019-316164","article-title":"Assessment and management of peripheral arterial disease: what every cardiologist should know","volume":"107","author":"Bao","year":"2021","journal-title":"Heart"},{"key":"2025050207470501700_bib104","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1111\/j.1432-2277.1998.tb01098.x","article-title":"Peripheral arterial disease as a predictor of outcome after renal transplantation","volume":"11","author":"M\u00e4kisalo","year":"1998","journal-title":"Transplant Int"},{"key":"2025050207470501700_bib105","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ejvs.2008.01.013","article-title":"Prevalence and risk factors of PAD among patients with elevated ABI","volume":"35","author":"Suominen","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025050207470501700_bib106","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5999\/aps.2012.39.3.227","article-title":"Utility of toe-brachial index for diagnosis of peripheral artery disease","volume":"39","author":"Park","year":"2012","journal-title":"Arch Plast Surg"},{"key":"2025050207470501700_bib107","first-page":"Cd003748","article-title":"Cilostazol for intermittent claudication","volume":"6","author":"Brown","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025050207470501700_bib108","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1053\/ajkd.2002.34885","article-title":"The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics","volume":"40","author":"Leskinen","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"2025050207470501700_bib109","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ejvs.2009.12.003","article-title":"PAD as a risk factor for mortality among patients with elevated ABI\u2014a clinical study","volume":"39","author":"Suominen","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025050207470501700_bib110","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1093\/eurheartj\/ehae179","article-title":"2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), and the European Society of Vascular Medicine (ESVM)","volume":"45","author":"Mazzolai","year":"2024","journal-title":"Eur Heart J"},{"key":"2025050207470501700_bib111","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2215\/CJN.09451209","article-title":"Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients","volume":"5","author":"Ogata","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025050207470501700_bib112","first-page":"2058460115583034","article-title":"Contrast-induced nephropathy in patients with chronic kidney disease and peripheral arterial disease","volume":"4","author":"Kroneberger","year":"2015","journal-title":"Acta Radiol Open"},{"key":"2025050207470501700_bib113","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4330\/wjc.v12.i2.76","article-title":"Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy","volume":"12","author":"Gupta","year":"2020","journal-title":"World J Cardiol"},{"key":"2025050207470501700_bib114","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/CIRCULATIONAHA.113.007003","article-title":"The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease","volume":"130","author":"Hiatt","year":"2014","journal-title":"Circulation"},{"key":"2025050207470501700_bib115","first-page":"486","article-title":"Exercise intensity during 6-minute walk test in patients with peripheral artery disease","volume":"114","author":"Farah","year":"2020","journal-title":"Arq Bras Cardiol"},{"key":"2025050207470501700_bib116","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/0003319717726934","article-title":"endothelial cell inflammation and antioxidant capacity are associated with 6-minute walk performance in patients with symptomatic peripheral artery disease","volume":"69","author":"Gardner","year":"2018","journal-title":"Angiology"},{"key":"2025050207470501700_bib117","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/hdi.12918","article-title":"Effectiveness of a resistance exercise program for lower limbs in chronic renal patients on hemodialysis: a randomized controlled trial","volume":"25","author":"Exel","year":"2021","journal-title":"Hemodial Int"},{"key":"2025050207470501700_bib118","doi-asserted-by":"publisher","first-page":"e700","DOI":"10.1161\/CIR.0000000000000727","article-title":"Implementation of supervised exercise therapy for patients with symptomatic peripheral artery disease: a science advisory from the American Heart Association","volume":"140","author":"Treat-Jacobson","year":"2019","journal-title":"Circulation"},{"key":"2025050207470501700_bib119","doi-asserted-by":"publisher","first-page":"e026136","DOI":"10.1161\/JAHA.122.026136","article-title":"Attendance at supervised exercise sessions and walking outcomes in peripheral artery disease: results from 2 randomized clinical trials","volume":"11","author":"Hammond","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2025050207470501700_bib120","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","article-title":"2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Gornik","year":"2024","journal-title":"Circulation"},{"key":"2025050207470501700_bib121","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/jamacardio.2021.3987","article-title":"Smoking cessation improves outcomes in patients with peripheral artery disease","volume":"7","author":"Creager","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2025050207470501700_bib122","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/j.jvs.2014.08.064","article-title":"Smoking cessation is associated with decreased mortality and improved amputation-free survival among patients with symptomatic peripheral artery disease","volume":"60","author":"Armstrong","year":"2014","journal-title":"J Vasc Surg"},{"key":"2025050207470501700_bib123","first-page":"D6110","article-title":"[Meaningful interventions for peripheral arterial disease: stopping primary referral to the vascular surgeon and angioplasty]","volume":"165","author":"Van Houten","year":"2021","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2025050207470501700_bib124","doi-asserted-by":"publisher","first-page":"CD000990","DOI":"10.1002\/14651858.CD000990.pub4","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025050207470501700_bib125","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1046\/j.1523-1755.2003.00860.x","article-title":"Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study","volume":"63","author":"Foley","year":"2003","journal-title":"Kidney Int"},{"key":"2025050207470501700_bib126","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.atherosclerosis.2018.05.049","article-title":"Risk of peripheral artery disease according to a healthy lifestyle score: the PREDIMED study","volume":"275","author":"L\u00f3pez-Laguna","year":"2018","journal-title":"Atherosclerosis"},{"key":"2025050207470501700_bib127","doi-asserted-by":"publisher","first-page":"609S","DOI":"10.1378\/chest.126.3_suppl.609S","article-title":"Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Clagett","year":"2004","journal-title":"Chest"},{"key":"2025050207470501700_bib128","doi-asserted-by":"publisher","first-page":"445","DOI":"10.7326\/0003-4819-156-6-201203200-00007","article-title":"Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"156","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"2025050207470501700_bib129","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/eurjpc\/zwab132","article-title":"Aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"28","author":"Pallikadavath","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2025050207470501700_bib130","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial","volume":"56","author":"Jardine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2025050207470501700_bib131","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jacc.2021.04.083","article-title":"Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease","volume":"78","author":"Eikelboom","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2025050207470501700_bib132","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ejvs.2009.06.002","article-title":"Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies","volume":"38","author":"Momsen","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025050207470501700_bib133","doi-asserted-by":"publisher","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","article-title":"Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2012","journal-title":"Ann Intern Med"},{"key":"2025050207470501700_bib134","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","author":"The Heart Protection Collaborative Group","year":"2007","journal-title":"J Vasc Surg"},{"key":"2025050207470501700_bib135","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"2025050207470501700_bib136","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/iwj.12085","article-title":"Cilostazol prevents foot ulcers in diabetic patients with peripheral vascular disease","volume":"12","author":"de Franciscis","year":"2015","journal-title":"Int Wound J"},{"key":"2025050207470501700_bib137","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jvs.2016.10.098","article-title":"Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery disease","volume":"65","author":"Zen","year":"2017","journal-title":"J Vasc Surg"},{"key":"2025050207470501700_bib138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8236903","article-title":"Role of cilostazol therapy in hemodialysis patients with asymptomatic peripheral arterial disease: a retrospective cohort study","volume":"2016","author":"Lim","year":"2016","journal-title":"Biomed Res Int"},{"key":"2025050207470501700_bib139","first-page":"Cd005262","article-title":"Pentoxifylline for intermittent claudication","volume":"9","author":"Salhiyyah","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025050207470501700_bib140","first-page":"Cd005262","article-title":"Pentoxifylline for intermittent claudication","volume":"10","author":"Broderick","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025050207470501700_bib141","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/bjs.8895","article-title":"Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication","volume":"99","author":"Stevens","year":"2012","journal-title":"Br J Surg"},{"key":"2025050207470501700_bib142","first-page":"370","article-title":"Pharmacokinetics of naftidrofuryl in patients with renal impairment","volume":"55","author":"Legallicier","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"2025050207470501700_bib143","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10157-012-0752-x","article-title":"Acute kidney injury associated with nafronyl oxalate overdose","volume":"17","author":"Kim","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"2025050207470501700_bib144","first-page":"1751","article-title":"Potential nephrotoxicity of intravenous infusions of naftidrofuryl oxalate","volume":"10","author":"Le Meur","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"2025050207470501700_bib145","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2215\/CJN.05600515","article-title":"CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia","volume":"11","author":"L\u00fcders","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025050207470501700_bib146","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1177\/0003319715603184","article-title":"Long-term mortality after invasive angiography and endovascular revascularization in patients with PAD having chronic kidney disease","volume":"67","author":"Gebauer","year":"2016","journal-title":"Angiology"},{"key":"2025050207470501700_bib147","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/ajkd.2001.25194","article-title":"Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients","volume":"38","author":"Reddan","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2025050207470501700_bib148","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1159\/000541146","article-title":"Outcomes of patients with critical limb ischemia and chronic kidney disease: a national perspective","volume":"14","author":"Rivera","year":"2024","journal-title":"Cardiorenal Med"},{"key":"2025050207470501700_bib149","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1097\/01.ASN.0000061776.60146.02","article-title":"Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs\u2019 National Surgical Quality Improvement Program","volume":"14","author":"O'Hare","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib150","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/01.ASN.0000105992.18297.63","article-title":"Postoperative mortality after nontraumatic lower extremity amputation in patients with renal insufficiency","volume":"15","author":"O'Hare","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib151","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/ejvs.2002.1767","article-title":"Infrainguinal arterial reconstruction for limb salvage in patients with end-stage renal disease","volume":"25","author":"Kimura","year":"2003","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2025050207470501700_bib152","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jvs.2020.08.032","article-title":"Systematic review and meta-analysis of outcomes of lower extremity peripheral arterial interventions in patients with and without chronic kidney disease or end-stage renal disease","volume":"73","author":"Anantha-Narayanan","year":"2021","journal-title":"J Vasc Surg"},{"key":"2025050207470501700_bib153","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/bcp.14521","article-title":"Quality and use of unlicensed vitamin D preparations in primary care in England: retrospective review of national prescription data and laboratory analysis","volume":"87","author":"Wan","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"2025050207470501700_bib154","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1681\/ASN.2006030201","article-title":"Peripheral arterial disease and renal transplantation","volume":"17","author":"Snyder","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2025050207470501700_bib155","first-page":"594","article-title":"Surgical techniques and procedures for kidney transplant recipients with severe atherosclerosis","volume":"15","author":"Nanmoku","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"2025050207470501700_bib156","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/TP.0000000000003137","article-title":"Summary of the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"2025050207470501700_bib157","doi-asserted-by":"publisher","first-page":"e13218","DOI":"10.1111\/ctr.13218","article-title":"Aortic bypass surgery for asymptomatic patients awaiting a kidney transplant: a word of caution","volume":"32","author":"Franquet","year":"2018","journal-title":"Clin Transplant"},{"key":"2025050207470501700_bib158","first-page":"3","article-title":"The evaluation of renal transplantation candidates: clinical practice guidelines","volume":"1","author":"Kasiske","year":"2001","journal-title":"Am J Transplant"},{"key":"2025050207470501700_bib159","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1358863X16689830","article-title":"Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients","volume":"22","author":"Patel","year":"2017","journal-title":"Vasc Med"},{"key":"2025050207470501700_bib160","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1097\/TP.0b013e31827eef36","article-title":"Effect of peripheral vascular disease on kidney allograft outcomes: a study of U.S. Renal Data System","volume":"95","author":"Brar","year":"2013","journal-title":"Transplantation"},{"key":"2025050207470501700_bib161","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/1358863X17703195","article-title":"Presence of peripheral artery disease in renal transplant outcomes\u2014don't throw the baby out with the bath water","volume":"22","author":"Shishehbor","year":"2017","journal-title":"Vasc Med"},{"key":"2025050207470501700_bib162","doi-asserted-by":"publisher","first-page":"e068769","DOI":"10.1136\/bmj-2021-068769","article-title":"Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis","volume":"376","author":"Chaudhry","year":"2022","journal-title":"BMJ"},{"key":"2025050207470501700_bib163","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/ctr.12720","article-title":"The survival benefit of kidney transplantation in the setting of combined peripheral arterial disease and end-stage renal failure","volume":"30","author":"Cassuto","year":"2016","journal-title":"Clin Transplant"},{"key":"2025050207470501700_bib164","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1038\/s41591-024-03043-1","article-title":"IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial","volume":"30","author":"Chertow","year":"2024","journal-title":"Nat Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf089\/62885992\/sfaf089.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/5\/sfaf089\/62885992\/sfaf089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/5\/sfaf089\/62885992\/sfaf089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:51:02Z","timestamp":1746190262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf089\/8107889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":164,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf089","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,4,7]]},"article-number":"sfaf089"}}